Sector Alert: Investors Wake Up with Spike in SkyPeople Fruit Juice (NASDAQ:SPU)

New York, NY - April 20, 2012 - www.InvestorIdeas.com, a global investor research portal for independent investors specializing in sector research issues a trading alert for China beverage stock SkyPeople Fruit Juice (NASDAQ:SPU) . The stock is trading at $1.85, up 0.30(19.35%) as of 10:18AM EDT with a high of $2.24 on volume of over 700,000 shares.

The stock moved on news from the Company providing supplementary information regarding cash balances as of its 2011 fiscal year end.
According to the press release, "At a time when there is speculation as to the credibility of certain Chinese companies, SkyPeople investors can be reassured that our cash balances have been independently verified and that we employ of a high degree of financial integrity in terms of our financial management systems," said Mr. Yongke Xue, SkyPeople's CEO. "Investors can have confidence in the strength of our balance sheet that enables us to take advantage of the growth opportunities available to us in our sector."
About SkyPeople Fruit Juice, Inc.
SkyPeople Fruit Juice, Inc., a Florida company, through its wholly-owned subsidiary Pacific Industry Holding Group Co., Ltd. , a Vanuatu company, holds 99.78% ownership interest in SkyPeople Juice Group Co., Ltd. ("SkyPeople ( China)"). SkyPeople (China) is engaged in the production and sales of fruit juice concentrates, fruit beverages, and other fruit related products in the PRC and overseas markets. Its fruit juice concentrates are sold to domestic customers and exported directly or via distributors. Fruit juice concentrates are used as a basic ingredient component in the food industry. Its brands, "Hedetang" and "SkyPeople", which are registered trademarks in the PRC, are positioned as high quality, healthy and nutritious end-use juice beverages. http://www.skypeoplefruitjuice.com
Research more China and beverage stocks with Investorideas.com stock directories : http://www.investorideas.com/dirs/stocklist.asp
Get Free investor news and stock alerts at Investorideas.com
Join Investor Ideas - Get 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks  
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; water and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, natural gas stocks, tech (includes cloud and social networking), defense stocks, nanotech, China stocks and agriculture.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising.
From time to time Investorideas.com buys shares in companies it features. As a policy, Investorideas.com does not short stocks
www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411
Source - www.Investorideas.com

Oceanic Environmental Solutions; A New Player in Frac Water Treatment and Remediation for Oil-contaminated Water

New York, NY - April 19, 2012 – Investorideas.com, a leader in sector research including water stocks and energy stocks , publishes the new company profile for Oceanic Environmental Solutions (OES), a private Canadian company focused on bringing water remediation solutions to oil and gas markets.

OES' Proprietary Enhanced Induced Air Flotation system is used independently or in conjunction with other water management solutions, which provides overall lower CAPEX and OPEX for their clients.

Visit the Company Profile at Investorideas.com

http://www.investorideas.com/CO/OES/

Contact:

Oceanic Environmental Solutions (OES)

780-930-7080

More info on Frac Water Industry at Investorideas.com read what industry experts say:

Energy and Water Series; Q&A Interview with Jud Hill, Managing Director of NGP Global Adaptation Partners

Research water stocks with the water stocks directory at Investorideas.com

Sign up for company and stock alerts at Investorideas.com

http://www.investorideas.com/Resources/Newsletter.asp

About InvestorIdeas.com:

InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas

Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by news submissions and online advertising and profile companies including Oceanic: Compensation Disclosure and disclaimers: www.InvestorIdeas.com/About/Disclaimer.asp and

http://www.investorideas.com/About/News/Clientspecifics.asp .

BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

For More Information Contact:

800 665 0411

Source: Water-Stocks.com, Investorideas.com

Solar News: Sunlogics Power Fund as Subsidiary of Salamon Group, Inc. (OTCQB:SLMU) Initiates First Phase of Its Rooftop Solar Projects in Williamson County, Tennessee

LAS VEGAS, NV - April 19, 2012 (Investorideas.com renewable energy newswire) Salamon Group, Inc. (OTCQB: SLMU) and General Motors Company (NYSE:GM) - Salamon Group, Inc. stated Thursday that it has initiated the first phase of its roof top solar installation in Williamson County Tennessee. These projects have total combined revenues of $3.3M over the life of the contract, and yields a levered IRR of approximately 25% for the company. The first phase consists of three installations, the first of three installations have now received final TVA-NES approval these project are expected to be completed by May 28 2012. Each Solar system in the first phase has an output of 200KW, totaling 600KW. The Company plans to continue building out the remaining 20 rooftops later this spring.

CEO Michael Matvieshen stated, "We have now started pulling construction permits for Brentwood MS, Brentwood HS, Edmondson ES in Williamson County Tennessee. I am pleased that these project's have now been initiated and have received their approvals to get underway. Building solar power systems on these types of public sector rooftops is one of the Company's Key strategic solar verticals."
About Salamon Group
Salamon Group, Inc., through its Sunlogics Power Fund Management Inc. division, is a solar energy project company specializing in the construction, management and acquisition of renewable energy power projects. Sunlogics Power also looks to acquire assets and other companies in the solar and renewable energy space that are a strategic fit. Sunlogics Power is also a project-acquiring partner of Sunlogics Plc and its Subsidiary as well as other third party project developers.
http://www.sunlogicspowerfund.com/
Sunlogics PLC majority partner and shareholder is General Motors Company (NYSE:GM). Sunlogics Power Fund Controls 30% of Sunlogics PLC. http://www.sunlogics.com.
SLMU cautions that statements made in press releases constitute forward-looking statements, and makes no guarantees of future performances and actual results/developments may differ materially from projections in forward-looking statements. Forward-looking statements are based on estimates and opinions of management at the time statements are made.
Contact:
Orsay Groupe, Inc.
William J. Nalley
305-515-8077
williamjnalley@yahoo.com
Published on Investorideas.com newswire
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp. Disclosure: SLMU is a paid customer on Investorideas,com , publishing press releases and company content on Investorideas.com and our syndicated blogs and global partners effective March 14 ,2012 (three months: one thousand per month and nine thousand equivalent in 144 shares)
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Medical Technology Stock Alert; PositiveID Corporation's (OTCBB:PSID) iglucose Mobile Health Solution for Diabetes Management to be Featured at CTIA Wireless Emerging Technology Awards Showcase

DELRAY BEACH, Fla. - April 19, 2012 (Investorideas.com newswire) - PositiveID Corporation (OTCBB:PSID), an emerging growth company and developer of advanced technologies for diabetes management as well as sophisticated airborne bio-threat detection systems for America's homeland defense, today announced its FDA-cleared iglucose(R) mobile health system for diabetes management will be featured at the CTIA Emerging Technology (E-Tech) Awards Showcase at the International CTIA Wireless 2012 show from May 8-10, 2012 at the Ernest N. Morial Convention Center in New Orleans, LA. iglucose will be showcased within the category entitled Enterprise & Vertical Market Solution: Healthcare & Wellness.

PositiveID's FDA-cleared iglucose uses mobile technology to revolutionize the way individuals with diabetes manage their condition. By seamlessly communicating data from glucometers to the iglucose diabetes management portal, glucose readings can be shared with family members and healthcare professionals. This makes it possible to improve care in a cost-effective manner. iglucose eliminates the burden of keeping logbooks and empowers individuals with diabetes to be more engaged in the self-management of their condition. Family members have greater peace of mind; now parents of children with diabetes can receive text messages to let them know their children are testing while at school. iglucose does not require the use of a cell phone or a wireless plan.
iglucose was designed with the needs of healthcare professionals and people with diabetes in mind. It is simple to use and conveniently fits within a pocket or purse. Usability tests conducted as part of the iglucose FDA review process demonstrated 100 percent of consumers were able to use the device regardless of their age. After initial enrollment there are no technology requirements for the end user. Users simply connect their glucometer to iglucose and push a button. The iglucose system creates a variety of reports and communicates according to the user's preferences via online access, email, fax or SMS text.
The iglucose system collects and transmits stored data from a variety of FDA-cleared blood glucose meters such as Johnson & Johnson LifeScan(R), Abbott FreeStyle(R), Bayer Contour (R), and Nipro Diagnostic(TM) True(TM) monitoring systems to a secure database via wireless cellular technology. The Company is continually adding to this list of supported glucose meters. For more information on iglucose, visit www.iglucose.com.
The International CTIA Wireless show draws more than 40,000 qualified attendees every year, occupies more than 300,000 sq. ft. of exhibit space, hosts over 1,000 exhibitors, attracts more than 1,100 press and analysts worldwide, and offers top-level speakers and the most comprehensive educational programming in the industry. CTIA--The Wireless Association(R) (www.ctia.org) is an international organization representing the wireless communications industry.
About PositiveID Corporation OTCBB:PSID)
PositiveID Corporation is an emerging growth developer of advanced technologies for diabetes management and rapid medical testing, as well as airborne bio-threat detection systems for America's homeland defense industry. Its wholly-owned subsidiary, Microfluidic Systems, or MFS, is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment.
For more information on PositiveID, please visit http://www.PositiveIDCorp.com.
Statements about PositiveID's future expectations, including the likelihood that PositiveID's M-BAND system is well positioned to take part the DHS $3.1 billion BioWatch Gen-3 opportunity, expected to be released in the first half of 2012, and is the only system of its kind that was demonstrated in the field under the DHS S&T BAND Program; the likelihood that M-BAND was the only successful system to emerge from the BAND program; the likelihood that the M-BAND instrument offers a number of advantages including decreased consumable and operating costs, a small footprint, a closed operating environment and significant flexibility of operation; the likelihood that M-BAND is the only system of its kind that has been successfully field tested indoors and outdoors, both domestically and internationally; the likelihood that M-BAND has significant benefits that set this technology apart and put PositiveID in a strong position to participate with large partners in the $3.1 billion BioWatch opportunity; and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID's actual results could differ materially from expected results. These risks and uncertainties include PositiveID's ability to successfully participate in the $3.1 billion BioWatch opportunity; as well as certain other risks. Additional information about these and other factors that could affect the Company's business is set forth in the Company's various filings with the Securities and Exchange Commission, including those set forth in the Company's 10-K filed on March 25, 2011, and 10-Qs filed on May 13, 2011, August 15, 2011, and November 14, 2011, under the caption "Risk Factors." The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.
CONTACT:
Allison Tomek
561-805-8000
atomek@positiveidcorp.com
Trilogy Capital Partners, Inc.
Darren Minton, President
Toll-free: 800-592-6067
info@trilogy-capital.com

PositiveID Corporation (OTCBB:PSID) is a featured biotech company on Investorideas.com
Visit the company profile: http://www.investorideas.com/CO/PSID/

Disclaimer/ Disclosure: Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. PositiveID Corporation (OTCBB:PSID) featured biotech company on Investorideas.com for 3 months effective January 30,2012 . Compensation: two hundred fifty thousand 144 shares for news release publication, syndication on blogs and related sites and email distribution and  company profile . More info: www.InvestorIdeas.com/About/Disclaimer.asp and disclosures: http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Mining Stocks; YALE (TSX-V: YLL) and Overlord Finalize Orofino Option – Work to Commence Shortly

VANCOUVER, British Columbia - April 19, 2012 (Investorideas.com Mining stocks Newswire) - Yale Resources Ltd. (TSX-V: YLL, OTCBB: YRLLF, and Frankfurt: YAB) is pleased to report that it has received $50,000 and 50,000 common shares from Overlord Capital Ltd. as the initial commitment for the recently finalized option of an up to 70% interest in Yale's wholly owned Orofino Property located in Sonora State, Mexico. The transaction is Overlord's "Qualifying Transaction". Yale will be the initial operator and will manage the exploration on the property.

Under the terms of the Option Agreement, Overlord may earn up to a 70% interest in the property by paying Yale $100,000 ($50,000 received), issue to Yale 1,300,000 shares in Overlord (50,000 received), and incur a total of $2,100,000 in exploration expenditures on the Property over a four year period.
The first year's requirement will be $200,000 in exploration expenditures followed by a further $400,000 in the following year, $750,000 in the third year and $750,000 in the final year of the Option Agreement. Subsequent share issuances of 500,000, 150,000, 350,000 and 250,000 shares on the first, second, third, and fourth year anniversaries will also be due in order to keep the Option Agreement in good standing.
About Yale Resources:
Yale Resources utilizes the project generator business model to maximize its exposure to discovery while minimizing shareholder risk. Yale currently has eight projects in its portfolio of which four are optioned with commitments totalling approximately $1.0M in expenditures during the next 12 months. At the same time Yale continues to work on its non-optioned properties as well as reviewing new projects.
On behalf of the Board,
"Ian Foreman"
Ian Foreman, P.Geo.
President
For additional information on Yale Resources please call the Company at 604-678-2531.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Statements in this press release, other than purely historical information, including statements relating to the Company's future plans and objectives or expected results, may include forward-looking statements. Forward-looking statements are based on numerous assumptions and are subject to all of the risks and uncertainties inherent in resource exploration and development. As a result, actual results may vary materially from those described in the forward-looking statements.
Contact:
Yale Resources Ltd.
400 - 409 Granville St.,
Vancouver, BC, Canada V6C 1T2
News Release #12-4
Ian Foreman
604-678-2531

Visit the YLL showcase profile at Investorideas.com
Request News and Info on YLL
Disclosure, Disclaimer/ Investorideas.com is paid by YLL to publish news and distribute content through Investordeas.com Newswire and its syndicated partners and blogs (five hundred per month)

Sector Alert: EnerNOC (NASDAQ:ENOC) Heats Up Renewable Energy Stocks Gaining over 11% on News

New York, NY - April 17, 2012 - www.InvestorIdeas.com, a global investor research portal specializing in sector research for independent investors issues a renewable energy stock alert for EnerNOC, Inc. (NasdaqGS: ENOC) trading at $7.26 , up 0.75 (11.52%) as of 11:03AM EDT . The stock moved on news that that National Grid selected EnerNOC's technology and services platform to manage natural gas consumption at approximately 4,000 commercial, institutional, and industrial customer sites in Brooklyn and Queens.
About EnerNOC Utility Solutions (NasdaqGS: ENOC)
EnerNOC Utility Solutions has teamed with hundreds of utilities and grid operators worldwide to meet their demand-side management objectives. Our Program Implementation group partners with leading utilities to deliver custom-tailored demand response and energy efficiency programs designed to maximize both cost-effectiveness and customer satisfaction within the commercial, industrial, and agricultural market segments. Our Consulting Services group supports a broad range of utility demand-side management activities, including potential assessments, program design and administration, load research, technology demonstrations, measurement and evaluation, and regulatory support. EnerNOC leverages its experience working with thousands of commercial, institutional, industrial, and agricultural sites, its SMART suite of energy management solutions, and its Network Operations Center (NOC), to deliver reliable load reductions and millions of kilowatt hours of energy savings each year. For more information, visit www.enernoc.com.

Research more energy efficient stocks on global stock exchanges - and up to 1400 renewable energy stocks at Investorideas.com http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp
Get Free investor news and stock alerts at Investorideas.com
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks: Join:   http://www.investorideas.com/membership/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; water and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, natural gas stocks, tech (includes cloud and social networking), defense stocks, nanotech, China stocks and agriculture.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Renewable Energy Stocks onFacebook.com
http://www.facebook.com/renewableenergystocks
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising.
From time to time Investorideas.com buys shares in companies it features. As a policy, Investorideas.com does not short stocks
www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411
Source - www.Investorideas.com

Solar News: Salamon Group, Inc. (OTCQB:SLMU) Tenders Offer to Shareholders and Board of Directors to Energy Conversion Devices (ENERQ)

LAS VEGAS, NV - April 17, 2012 (Investorideas.com renewable energy newswire) Salamon Group, Inc. (OTCQB: SLMU) has sent a letter of offer to the board of directors and the Company's Registration Offices (CRO) of Energy Conversion Devices (ENERQ). This offer is for up to 100% of all issued and outstanding shares of the Company. The offer is in exchange for up to 5 million shares of Salamon Group, Inc. (SLMU).

Energy Conversion loss-carry forwards are over $1 billion USD. The transaction as contemplated, would complete after receipt of all corporate documentation for SGI to perform final due diligence and would be subject to relevant SEC regulations and requirements.
Michael Matvieshen, CEO, SLMU, stated, "We believe this type transaction would have a positive impact on our business model." He went on to say, "A bank of loss-carry forwards is a valuable asset, if they are acquired for the right price. Energy Conversion shareholders are currently set to receive nothing but a total loss because of the Chapter 11 filing. The current Energy Conversion shareholders position based on the Chapter 11 disposition of assets receive nothing. Our offer allows shareholders of ENERQ to have an opportunity to recover value that they would not be able to with their current holdings because of the Chapter 11 filing."
Shareholders of Energy Conversion are encouraged to call or email "The Orsay Groupe" for more details, at info@orsaygroupe.com or phone 305-515-8077
About Energy Conversation Devices.
Energy Conversion Devices (ENERQ) has a renowned 51 year history since its formation in Detroit, Michigan and has been a pioneer in materials science and renewable energy technology development. The company has been awarded over 500 U.S. patents and international counterparts for its achievements. ECD's United Solar wholly owned subsidiary has been a global leader in building-integrated and rooftop photovoltaics for over 25 years. The company manufactures sells and installs thin-film solar laminates that convert sunlight to clean, renewable energy using proprietary technology. UNI-SOLAR� brand products are unique because of their flexibility, light weight, ease of installation, durability, and real-world energy production. For more information, please visit Energy Conversion Devices on the web at energyconversiondevices.com
About Salamon Group
Salamon Group, Inc. and its Sunlogics Power Fund Management, Inc. division, is a solar and renewable energy company specializing in the acquisition, construction and management of renewable energy power projects and companies. It is a project-acquiring partner of Sunlogics Plc and its subsidiary as well as other third party project developers. The Company also takes positions in other solar and renewable energy project producing companies that are a strategic fit within the Company's overall strategy.
For further information, Orsay Groupe, Inc. 305-515-8077 and/or visit: http://www.sunlogicspowerfund.com/ www.sunlogics.com
SLMU cautions that statements made in press releases constitute forward-looking statements, and makes no guarantees of future performances and actual results/developments may differ materially from projections in forward-looking statements. Forward-looking statements are based on estimates and opinions of management at the time statements are made.
Contact:
Orsay Groupe, Inc.
William J. Nalley
305-515-8077
williamjnalley@yahoo.com
Published on Investorideas.com newswire
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp. Disclosure: SLMU is a paid customer on Investorideas,com , publishing press releases and company content on Investorideas.com and our syndicated blogs and global partners effective March 14 ,2012 (three months: one thousand per month and nine thousand equivalent in 144 shares)
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Monday's NASDAQ Top % Winners: ECYT, HAUP, SAPX, USAT

New York, NY - April 17, 2012 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Monday April 16th. The Nasdaq Composite fell 22.93 (-0.76%) to close at 2,988.40.

Endocyte, Inc. (NASDAQ:ECYT) shares soared $3.82 (100.53%) to end at $7.62
following news that Merck (NYSE: MRK) and Endocyte entered into an agreement to develop and commercialize Endocyte's novel investigational therapeutic candidate vintafolide (EC145). The stock is continuing its gains this morning in Tuesday’s trading.
Hauppauge Digital, Inc. (NASDAQ:HAUP) shares gained 0.37 (37.37%) to close at $1.36 without any official news. Hauppauge Digital Inc. is a developer of analog and digital television tuner and other products for the personal computer market. Through Hauppauge Computer Works, Inc., Hauppauge Digital Europe Sarl and PCTV Systems Sarl subsidiaries, the Company designs, develops, manufactures and markets analog.
Seven Arts Pictures PLC(NASDAQ:SAPX) shares gained 0.025 (20.83%)to close at $0.145 after the company said that it had terminated negotiations for a $3,000,000 convertible debenture, the proceeds of which were to have been used for reacquisition of approximately twelve of the Company's motion pictures controlled by an existing lender.
USA Technologies, Inc. (NASDAQ:USAT) shares rose 0.25 (18.25%) to end at $1.62 as the company projects to earn $300,000 on revenue of $7.5 million in its fiscal third-quarter, compared to a year ago loss of $940,170 on revenue of $5.5 million.
Get Free investor news and stock alerts at Investorideas.com
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks: Join:   http://www.investorideas.com/membership/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; water and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, natural gas stocks, tech (includes cloud and social networking), defense stocks, nanotech,   China  stocks and agriculture.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising.
From time to time Investorideas.com buys shares in companies it features. As a policy, Investorideas.com does not short stocks
www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411
Source - www.Investorideas.com

Technology Incubator Los Angeles Syndicate of Technology (OTCQB: LAST) Reports Biotech Portfolio Company Receives IRB Approval

Santa Monica, CA - April 16, 2012 (Investorideas.com Newswire) Los Angeles Syndicate of Technology, Inc. (OTCQB: LAST), a publicly-traded venture fund and technology incubator, is pleased to announce that its portfolio company, Sanguine BioSciences, Inc. ("Sanguine"), has received approval from the Institutional Review Board ("IRB") to collect Biospecimen and Clinical Data from Patients diagnosed with Multiple Sclerosis, Alzheimer's Disease, and Parkinson's Disease.

The approval by the IRB increases Sanguine's addressable customer markets by allowing Sanguine to collect blood, cerebral spinal fluid, and medical records from a broader base of potential patients. The IRB is a committee that has been formally designated to approve, monitor, and review biomedical and behavioral research involving humans.
Brian Neman, Founder and Chief Executive Officer, commented: "This marks Sanguine's most significant milestone to date. Not only does it enable us to serve many more research organizations and further the field of drug and biomarker research, but it will also significantly increase our capacity to empower those patients suffering from neurodegenerative and neurological disorders. We founded Sanguine with the vision of empowering patients and accelerating Personalized Medicine research and development, and this milestone is an important step to achieving that vision."
Sanguine currently serves over 60 customers through its global network of ten distributors in nine countries including customers like Harvard Medical School, Vanderbilt University, USC, UCLA, Lonza Group, Seracare, and Cambridge Bioscience. The company has surpassed $100,000 of revenue from USA, Canada, UK, France, Spain, Germany, Italy, Singapore, Japan, Korea, UK, Russia and Israel, with a current pipeline of over 160 purchase orders.
About Los Angeles Syndicate of Technology - www.last.vc
Los Angeles Syndicate of Technology, Inc. (OTC: LAST) is a publicly traded Business Development Company (BDC) operating as a venture fund and technology incubator that creates, builds, and invests in web and mobile technology companies. LAST develops digital media, social networking, and life sciences products in its technology incubator, and has a portfolio of six companies at different stages of development. LAST's mission is to foster technology innovation in Los Angeles by partnering with the most talented entrepreneurs of southern California and providing them with the capital, support and tools to bring their ideas to market and commercialize their products.
About Sanguine Biosciences, Inc. - sanguinebio.com
Sanguine Biosciences, Inc. ("Sanguine") is an international supplier of DNA data and bio-specimen to research organizations for the development of personalized medicines. Sanguine provides highly viable primary human cells and tissues to both the academic and industrial life science research communities through a new direct-to-patient platform. The current product offering spans customers' needs in the In Vitro Research & Development stage of Drug Development. Sanguine's vision is to develop into the global leader in high quality cells and tissues for life science research and development.
Forward-Looking Statements
Statements included in this release related to Los Angeles Syndicate of Technology, Inc. and its portfolio companies constitute or may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as the inherent uncertainty of investing in early-stage technology companies, the technological and financial difficulties inherent in these activities, and the Company's ability to estimate accurately net revenues due to variability in size, scope and duration of projects. Further information on potential risk factors that could affect the Company's financial results can be found in the Company's reports filed with the Securities and Exchange Commission.
Contact Information
Contact:
Los Angeles Syndicate of Technology, Inc.
Bryce Knight
(310) 694-0640
www.last.vc
Sanguine Biosciences accelerates Personalized Medicine discovery by providing biological and clinical data, including biospecimen and medical records to researchers, through a direct-to-patient platform that empowers patients in drug and biomarker research. Thousands of patients' biospecimen and medical information are needed to develop new drug and diagnostic, and the company's proprietary model enables it to collect, and ultimately provide patient biospecimen and clinical data much more quickly and less costly than current market standards.

• $100,000 in Revenue to Date
• $55,000 in Revenue in 2012
• 60 Customers including
• 10 distributiors selling to USA, Canada, UK France, Spain, Germany, Italy, Singapore, Japan, Korea, UK, Russia, Israel
• 161 open purchase orders
• The market size for patient and non-patient donor-derived biospecimens is estimated to be >$1B and estimated to grow to >$2.5B by 2015.

About Institutional Review Board
An institutional review board (IRB), also known as an independent ethics committee (IEC) or ethical review board (ERB), is a committee that has been formally designated to approve, monitor, and review biomedical and behavioral research involving humans. In the United States, the Food and Drug Administration (FDA) and Department of Health and Human Services (specifically Office for Human Research Protections) regulations have empowered IRBs to approve, require modifications in planned research prior to approval, or disapprove research. IRBs are responsible for critical oversight functions for research conducted on human subjects that are scientific, ethical, and regulatory.
Disclaimer: Invesorideas.com sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising.
Disclosure: Invesorideas.com was compensated by LAST: OB for previous news release and content distribution unrelated to this release. Investorideas.com was not compensated for this news release distribution
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Medical Technology Stock Alert; PositiveID Corporation's (OTCBB:PSID) iglucose Mobile Health Solution Makes Significant Progress With Active Customer Deployments

DELRAY BEACH, Fla. - April 16, 2012 (Investorideas.com newswire) - PositiveID Corporation (OTCBB:PSID), an emerging growth company and developer of advanced technologies for diabetes management as well as sophisticated airborne bio-threat detection systems for America's homeland defense, today announced significant progress with the initial deployment of its FDA-cleared iglucose(TM) mobile health system for diabetes management. The iglucose System is currently being trialed by a leading health insurer, a large consumer healthcare products company and an international telecommunications provider. The Company also recently announced the use of iglucose in a trial with a leading global pharmaceutical company.

PositiveID's FDA-cleared iglucose System is a convenient and easy-to-use wireless solution designed to empower individuals with diabetes to become more engaged in the self-management of their condition. iglucose seamlessly communicates blood glucose data from glucometers to the iglucose diabetes management portal, where reports are generated and can be shared with family members and healthcare professionals, making it possible to improve care in a cost-effective manner. The iglucose system communicates according to the user's preferences via online access, email, fax or SMS text. iglucose eliminates the burden of keeping logbooks and enables individuals with diabetes to proactively take control of their glucose levels and treatment regimens. iglucose does not require the use of a cell phone or a wireless plan.
"Many large organizations are currently trialing iglucose, from one of the largest health insurers in the U.S., to one of the largest consumer healthcare products companies in the world," stated William J. Caragol, PositiveID's Chairman and CEO. "We are providing this progress report following our announcement last week that we made iglucose available for pre-order for consumers. We received a very positive response and therefore want to update the investor community as well as those with diabetes about our next steps."
The iglucose system collects and transmits stored data from a variety of FDA-cleared blood glucose meters such as Johnson & Johnson LifeScan(R), Abbott FreeStyle(R), Bayer Contour (R), and Nipro Diagnostic(TM) True(TM) monitoring systems to a secure database via wireless cellular technology. PositiveID is continually adding to this list of supported glucose meters. For more information on iglucose, visit www.iglucose.com.
About PositiveID Corporation OTCBB:PSID)
PositiveID Corporation is an emerging growth developer of advanced technologies for diabetes management and rapid medical testing, as well as airborne bio-threat detection systems for America's homeland defense industry. Its wholly-owned subsidiary, Microfluidic Systems, or MFS, is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment.
For more information on PositiveID, please visit http://www.PositiveIDCorp.com.
Statements about PositiveID's future expectations, including the likelihood that PositiveID's M-BAND system is well positioned to take part the DHS $3.1 billion BioWatch Gen-3 opportunity, expected to be released in the first half of 2012, and is the only system of its kind that was demonstrated in the field under the DHS S&T BAND Program; the likelihood that M-BAND was the only successful system to emerge from the BAND program; the likelihood that the M-BAND instrument offers a number of advantages including decreased consumable and operating costs, a small footprint, a closed operating environment and significant flexibility of operation; the likelihood that M-BAND is the only system of its kind that has been successfully field tested indoors and outdoors, both domestically and internationally; the likelihood that M-BAND has significant benefits that set this technology apart and put PositiveID in a strong position to participate with large partners in the $3.1 billion BioWatch opportunity; and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID's actual results could differ materially from expected results. These risks and uncertainties include PositiveID's ability to successfully participate in the $3.1 billion BioWatch opportunity; as well as certain other risks. Additional information about these and other factors that could affect the Company's business is set forth in the Company's various filings with the Securities and Exchange Commission, including those set forth in the Company's 10-K filed on March 25, 2011, and 10-Qs filed on May 13, 2011, August 15, 2011, and November 14, 2011, under the caption "Risk Factors." The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.
CONTACT:
Allison Tomek
561-805-8000
atomek@positiveidcorp.com
Trilogy Capital Partners, Inc.
Darren Minton, President
Toll-free: 800-592-6067
info@trilogy-capital.com

PositiveID Corporation (OTCBB:PSID) is a featured biotech company on Investorideas.com
Visit the company profile: http://www.investorideas.com/CO/PSID/

Disclaimer/ Disclosure: Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. PositiveID Corporation (OTCBB:PSID) featured biotech company on Investorideas.com for 3 months effective January 30,2012 . Compensation: two hundred fifty thousand 144 shares for news release publication, syndication on blogs and related sites and email distribution and  company profile . More info: www.InvestorIdeas.com/About/Disclaimer.asp and disclosures: http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Pacific Therapeutics Ltd. (PT.CNSX) PROGRESS OF CLINICAL DEVELOPMENT

PROGRESS OF CLINICAL DEVELOPMENT VANCOUVER, BRITISH COLUMBIA – April 16, 2012 (Investorideas.com Newswire) Pacific Therapeutics Ltd. (PT.CNSX) (the “Company”) is pleased to provide an update on the progress of the clinical development of PTL-202. As previously announced the Company has engaged CRBIO of India to conduct a drug drug interaction study of PTL-202 and its components. CRBio has submitted the PTL-202 drug-drug interaction clinical trial protocol to the Central Drugs Standard Control Organization Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India, New Delhi, India.

The clinical study protocol is currently being reviewed by the Central Drugs Standard Control Organization ( India 's pharmaceutical regulatory authority). The study will be conducted once this regulatory approval is received, which is expected this quarter. The study protocol calls for dosing of 12 normal healthy adult males. This an open label, non randomized, three treatment, three period single dose study. Once enrolment is completed the study should only take 1 month to complete.

The lack of any drug drug interaction will be a positive result and signal the continued clinical development of PTL-202. CRBio is 'full service' contract research organization. It is set up in a centrally located area in Hyderabad India . The facility is spread over 20,000 sq.ft. in well laid out areas with operations such as Clinical, Bioanalytical, Pharmacokinetic & Statistical, QA & RA , QC . With 4 full time doctors plus paramedical staff, clinics consist of 72 beds and CRBio has a 3,000 volunteer database and a state of the art bioanalytical laboratory. CRBio as an independent contractor has completed over 150 BA/BE (Bioavailability Bioequivalence) projects similar to the PTL-202 drug drug interaction study.

ABOUT PACIFIC THERAPEUTICS LTD. (http://www.pacifictherapeutics.com/)

Pacific Therapeutics Ltd is a clinical stage specialty pharmaceutical company focused on the identification and development of drug candidates to treat diseases of excessive scarring (fibrosis). The company's lead drug candidate PTL-202 is a combination of Pentoxifylline (a FDA approved drug used for treating intermittent claudication) and N-Acetyl-Cysteine (NAC) an amino acid and an extremely potent and important antioxidant. PTL-202 is currently being reviewed for initial trials in humans which are expected to commence in 2012. PTL-202 a combination of approved drugs focused on treating fibrosis such as Idiopathic Pulmonary Fibrosis and Liver Cirrhosis.

The Company's strategy includes reformulating approved drugs to increase efficacy and patient compliance, completing the further clinical testing, manufacturing and other regulatory requirements sufficient to seek marketing authorizations. This strategy may reduce the risk, time and cost of developing therapies for fibrosis by avoiding the risks associated with basic research and using compounds with unknown safety and toxicity profiles.

FORWARD LOOKING STATEMENTS Certain statements included in this press release constitute forward-looking information or statements (collectively, “forward-looking statements”), including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. The forward-looking statements are not historical facts but reflect current expectations regarding future results or events.

This press release contains forward looking statements. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors. Readers should not place undue reliance on the Company's forward-looking statements, as the Company's actual results, performance or achievements may differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements if known or unknown risks, uncertainties or other factors affect the Company's business, or if the Company's estimates or assumptions prove inaccurate. Therefore, the Company cannot provide any assurance that such forward-looking statements will materialize. The Company does not undertake to update any forward-looking information, except as, and to the extent required by, applicable securities laws.

On Behalf of the Board of Directors /s/ Doug Unwin Douglas H. Unwin, CEO & President

(604) 738-1049

unwin@pacifictherapeutics.com www.pacifictherapeutics.com

Water Stocks Investor Alert: Primo Water (PRMW) Top Gainer on NASDAQ in Morning Trading

New York, NY - April 13, 2012 (Investorideas.com water stocks newswire) Investorideas.com, a leader in sector research including water stocks issues a trading alert for water stock Primo Water Corporation (NasdaqGM:PRMW), trading at $2.07, up 0.47(29.53%) 10:46AM EDT on over 2.4 Million shares. Primo is the top percentage gainer on NASDAQ in the morning session.
The Company reported today it has received a commitment from a senior lender to enter into a new long-term $20 million senior revolving credit facility. Also, the Company expects to close a term loan for up to an additional $15 million with a separate lender, secured by certain fixed assets of the Company.
About Primo Water Corporation
Primo Water Corporation (Nasdaq:PRMW) is a leading provider of water dispensers, environmentally responsible bulk bottled water and premier sparkling beverage appliances sold through major retailers throughout the United States and Canada. Learn more about Primo Water at www.primowater.com and www.primoflavorstation.com.

Linkedin.com: Water Stocks - Social network for investors following water stocks
Research water stocks with the global water stocks directory including TSX, OTC, NASDAQ, NYSE, AIM, HONG KONG, ASX water stocks
Sign up for free investor newsletters and water stock alerts at Investor Ideas
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by news submissions and online advertising. Compensation Disclosure and disclaimers: www.InvestorIdeas.com/About/Disclaimer.asp, http://www.investorideas.com/About/News/Clientspecifics.asp BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
For More Information Contact:
Web Site: www.InvestorIdeas.com www.water-stocks.com
800 665 0411

Solar News: Salamon Group (OTCQB:SLMU) Completes Acquisition of Eco Energy Solutions of Australia and Appoints CEO Gary Yost to the Board of Directors of Salamon Group

LAS VEGAS, NV - April 13, 2012 (Investorideas.com renewable energy newswire) Salamon Group, Inc. (OTCQB: SLMU) announces that Sunlogics Power, its wholly owned subsidiary (www.sunlogicspowerfund.com), has successfully completed final closing documentation on Eco Energy Solutions Pty Limited (ECO) in exchange for 8 million shares of Salamon Group, Inc. (SGI). The transaction was valued at 8 million dollars.

Eco Energy is a successful Australian-based renewable energy company with revenues of approximately 13 million USD and an EBITA of $0.960 million for year ending 2011 and ECO is on track to exceed those numbers this year. This transaction is immediately accretive to Salamon Group. ECO shareholders have agreed to take secured debt against ECO and its assets until the Authorized capital in Salamon Group, Inc. has been increase to allow for the conversion into equity.
At the end of February 2012 Eco Energy had installed 2,630 domestic systems through its contracts which started in May 2010. The contracts cover all of the state of Tasmania and all of central Victoria.
Michael Matvieshen, CEO, Salamon Group, commented, "Eco brings value to our shareholders in several ways which include the experience it has in the southern hemisphere for renewable energy project development. With its vast array of contacts, it opens up a very large and lucrative market for us. Together we expect to have a real and competitive footprint in these rapidly expanding markets."
Additionally, Mr. Gary Yost, the Managing Director of Eco Energy, will assume a seat on the Board of Directors of Sunlogics Power Fund and Salamon Group. Mr. Yost brings industry experience and contacts that have allowed him to create a "one stop shop" methodology to take any project from conception through to design, supply, installation and commissioning. Mr. Yost has overseen the growth of a client base that includes all levels of government, private and public utilities and projects that meet the needs of commercial and individual clients, as well as a number of overseas projects.
Mr. Matvieshen, CEO, Salamon Group, further stated, "It's excellent to be working with Gary as he has built a company from the ground up. He understands the business challenges and will be a valuable member of our 'go to market' team worldwide."
ECO will in turn benefit from SGIs' business synergies, such as accessing the CTIEC relationship and the financing investment banking relationships that are already in place at SGI.
ABOUT ECO ENERGY SOLUTIONS
Eco Energy Solutions specializes in the Design, Supply, Installation, Commissioning and Maintenance of Solar PV, Solar Hot water, Wind Turbine and Micro/Mini Hydro projects. Eco Energy Solutions (Australia) Pty Ltd is a very dynamic Australian business specializing in the Renewable Energy sector. We provide a full Integrated Systems House Solution service to all aspects of the Renewable Energy industry. We are involved in the leading projects in Australia in this sector. http://www.ecoenergysolutions.com.au/
About Salamon Group
Salamon Group, Inc. and its Sunlogics Power Fund Management, Inc. division, is a solar and renewable energy company specializing in the acquisition, construction and management of renewable energy power projects and companies. It is a project-acquiring partner of Sunlogics Plc and its subsidiary as well as other third party project developers. The Company also takes positions in other solar and renewable energy project producing companies that are a strategic fit within the Company's overall strategy.
For further information, Orsay Groupe, Inc. 305-515-8077 and/or visit: http://www.sunlogicspowerfund.com/ www.sunlogics.com
SLMU cautions that statements made in press releases constitute forward-looking statements, and makes no guarantees of future performances and actual results/developments may differ materially from projections in forward-looking statements. Forward-looking statements are based on estimates and opinions of management at the time statements are made.
Contact:
Orsay Groupe, Inc.
William J. Nalley
305-515-8077
williamjnalley@yahoo.com
Published on Investorideas.com newswire
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp. Disclosure: SLMU is a paid customer on Investorideas,com , publishing press releases and company content on Investorideas.com and our syndicated blogs and global partners effective March 14 ,2012 (three months: one thousand per month and nine thousand equivalent in 144 shares)
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Medical Technology Stock Alert; PositiveID Corporation (OTCBB:PSID) Offers iglucose Mobile Health Solution to Rural Healthcare Providers

DELRAY BEACH, Fla. - April 13, 2012 (Investorideas.com newswire) - PositiveID Corporation (OTCBB:PSID), an emerging growth company and developer of advanced technologies for diabetes management as well as sophisticated airborne bio-threat detection systems for America's homeland defense, today announced it is offering its FDA-cleared iglucose(R) mobile health system for diabetes management to rural healthcare providers, who care for approximately 62 million people in the U.S. To promote its awareness among rural healthcare providers, iglucose will be demonstrated at the National Rural Health Association's 35th Annual Rural Health Conference from April 17-20, 2012, at the Hyatt Regency Denver, Colorado Convention Center, in conjunction with healthcare solutions provider Merge-MD in booth #213.

PositiveID's FDA-cleared iglucose System uses mobile technology to revolutionize the way individuals with diabetes manage their condition. By seamlessly communicating data from glucometers to the iglucose diabetes management portal, glucose readings can be shared with family members and healthcare professionals, making it possible to improve care in a cost-effective manner. The iglucose system creates a variety of reports and communicates according to the user's preferences via online access, email, fax or SMS text. iglucose eliminates the burden of keeping logbooks and empowers individuals with diabetes to be more engaged in the self-management of their condition. iglucose does not require the use of a cell phone or a wireless plan.
"The response to iglucose from our customers and prospects is overwhelming. iglucose is a perfect rural tele-health solution for people with diabetes and those who care for them," stated Scott Griffith, Chief Operating Officer of Merge-MD. "Most people with diabetes need to be seen every 90 days, which can be a challenge when many endocrinologists and diabetes educators are located in major cities, not small towns. With iglucose, information can be shared at any time with healthcare professionals who are hundreds of miles away."
The iglucose system collects and transmits stored data from a variety of FDA-cleared blood glucose meters such as Johnson & Johnson LifeScan(R), Abbott FreeStyle(R), Bayer Contour (R), and Nipro Diagnostic(TM) True(TM) monitoring systems to a secure database via wireless cellular technology. PositiveID is continually adding to this list of supported glucose meters. For more information on iglucose, visit www.iglucose.com.
The National Rural Health Association's 35th Annual Rural Health Conference nation's largest rural health conference, created for all of those with an interest in rural health care, including rural health practitioners, hospital administrators, clinic directors and lay health workers, social workers, state and federal health employees, academics, community members, and all others interested in rural health care.
About Merge-MD
Merge-MD is an innovative healthcare solutions company founded and focused on how health information technology (including electronic health and medical records), processes and people can work together to advance the quality of healthcare. Merge-MD believes electronic health records should follow patients in real time so healthcare providers can make fast, safe decisions, reduce costs by eliminating redundant care and improve the quality of care overall.
About PositiveID Corporation OTCBB:PSID)
PositiveID Corporation is an emerging growth developer of advanced technologies for diabetes management and rapid medical testing, as well as airborne bio-threat detection systems for America's homeland defense industry. Its wholly-owned subsidiary, Microfluidic Systems, or MFS, is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment.
For more information on PositiveID, please visit http://www.PositiveIDCorp.com.
Statements about PositiveID's future expectations, including the likelihood that PositiveID's M-BAND system is well positioned to take part the DHS $3.1 billion BioWatch Gen-3 opportunity, expected to be released in the first half of 2012, and is the only system of its kind that was demonstrated in the field under the DHS S&T BAND Program; the likelihood that M-BAND was the only successful system to emerge from the BAND program; the likelihood that the M-BAND instrument offers a number of advantages including decreased consumable and operating costs, a small footprint, a closed operating environment and significant flexibility of operation; the likelihood that M-BAND is the only system of its kind that has been successfully field tested indoors and outdoors, both domestically and internationally; the likelihood that M-BAND has significant benefits that set this technology apart and put PositiveID in a strong position to participate with large partners in the $3.1 billion BioWatch opportunity; and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID's actual results could differ materially from expected results. These risks and uncertainties include PositiveID's ability to successfully participate in the $3.1 billion BioWatch opportunity; as well as certain other risks. Additional information about these and other factors that could affect the Company's business is set forth in the Company's various filings with the Securities and Exchange Commission, including those set forth in the Company's 10-K filed on March 25, 2011, and 10-Qs filed on May 13, 2011, August 15, 2011, and November 14, 2011, under the caption "Risk Factors." The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.
CONTACT:
Allison Tomek
561-805-8000
atomek@positiveidcorp.com
Trilogy Capital Partners, Inc.
Darren Minton, President
Toll-free: 800-592-6067
info@trilogy-capital.com

PositiveID Corporation (OTCBB:PSID) is a featured biotech company on Investorideas.com
Visit the company profile: http://www.investorideas.com/CO/PSID/

Disclaimer/ Disclosure: Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. PositiveID Corporation (OTCBB:PSID) featured biotech company on Investorideas.com for 3 months effective January 30,2012 . Compensation: two hundred fifty thousand 144 shares for news release publication, syndication on blogs and related sites and email distribution and  company profile . More info: www.InvestorIdeas.com/About/Disclaimer.asp and disclosures: http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Solar News: Salamon Group Inc. (OTCQB:SLMU) Appoints NCP Northland Capital Partners Inc. International as Their Designated Investment Banker

LAS VEGAS, NV - April 12, 2012 (Investorideas.com renewable energy newswire) Salamon Group, Inc. (OTCQB: SLMU) a leading edge green energy company, is pleased to announce that it has retained NCP Northland Capital Partners, Inc. (NCP) as the company's investment banker. NCP will assist with the Company's next round of financing, as well as, advise and assist with its needs including transitioning to more senior exchanges such as the NASDAQ and TSX.

NCP Northland Capital Partners Inc. (NCP) is an employee-owned securities firm that is a client-focused financial services firm targeting fast-growing companies in the small and mid-cap markets. NCP has completed over $2.2 Billion of funding for its clients. Some of these clients include: New Zealand Energy, Innergex Renewable Energy, Finavera Wind Energy, Nextraction Energy, and AMP Solar Group.
Michael Matvieshen, CEO Salamon Group, stated, "We are very pleased with this agreement, NCP employs two of the top rated special situations analysts in the 'Clean Tech' sector and their understanding of our sector will complement our international and global business." Mr. Matvieshen went on to say, "Additionally, because NCP is a full service Investment Bank, they have abilities from arranging funding to sponsor companies in graduating listings to higher exchanges which are important next steps for us."
About NCP Northland Capital Partners:
NCP Northland Capital Partners (USA) Inc. ("NCP USA"), a member of FINRA, is an affiliated company to NCP Northland Capital Partners Inc. ("NCP Canada"). NCP USA is head quartered in Toronto and provides U.S. domiciled institutional customers with NCP Canada produced research on Canadian listed issuers in the following areas: mining and resources, industrial and infrastructure, clean technology and technology, telecom and media, and life sciences and special situations. Through NCP Canada's exchange memberships, NCP USA can provide U.S. institutional customers with direct execution of Canadian exchange listed issuers. NCP USA can also provide U.S. institutional customers with new issue and private placement opportunities.
About Salamon Group
Salamon Group, Inc. and its Sunlogics Power Fund Management, Inc. division, is a solar and renewable energy company specializing in the acquisition, construction and management of renewable energy power projects and companies. It is a project-acquiring partner of Sunlogics Plc and its subsidiary as well as other third party project developers. The Company also takes positions in other solar and renewable energy project producing companies that are a strategic fit within the Company's overall strategy.
For further information, Orsay Groupe, Inc. 305-515-8077 and/or visit: http://www.sunlogicspowerfund.com/ www.sunlogics.com
SLMU cautions that statements made in press releases constitute forward-looking statements, and makes no guarantees of future performances and actual results/developments may differ materially from projections in forward-looking statements. Forward-looking statements are based on estimates and opinions of management at the time statements are made.
Contact:
Orsay Groupe, Inc.
William J. Nalley
305-515-8077
williamjnalley@yahoo.com
Published on Investorideas.com newswire
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp. Disclosure: SLMU is a paid customer on Investorideas,com , publishing press releases and company content on Investorideas.com and our syndicated blogs and global partners effective March 14 ,2012 (three months: one thousand per month and nine thousand equivalent in 144 shares)
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894